Percentage of Risk Management Plan review for new drug decisions completed within service standard (English, French, CSV)
Percentage of Risk Management Plan review for new drug decisions completed within service standard: English/French CSV file (13 KB) you can open as a table, filter, chart and export up to 10,000 rows. From Health Canada, updated Jul 2025.
- Format
- CSV
- Access
- Table on demand (prepared when opened)
- Size
- 13,502 bytes
- Publisher-reported update
- 2025-07-10
Risk Management Plan reviews protect Canadians from preventable hazards, and contribute to effective engagement with partners and stakeholders - in view of the department's reliance on shared responsibilities. This indicator measures post-market effectiveness in providing Canadians with access to safe, effective and quality health products in a timely manner. Risk Management Plan reviews are an important component of improving the health and safety of Canadians.
Data overview
- Formats
- CSV
- File languages
- English, French
- Available actions
- Explore table (prepared automatically) · Access original file
Sample rows
The first 10 rows, as CanQuery read them from the start of the publisher's file on 2026-11-10. Showing 20 of 23 columns.
| Lead_Bureau | Bureau_principale | Product_Line | Type_de_produit | DSTS_No | SAP_No | Product_Name-Nom_du_produit | Active_Ingred-Ingredient_actif | Review_Type | Type_dexamen | Date_Received | Date_de_reception | Date_Assigned | Date_assignee | Date_Finish | Date_de_fin | Missed_Greater_7 | Missed_Within_7 | Completed_Target-Cible_terminee | Fiscal_Year-Année_fiscale |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MBBNHPB | BPBBSNC | Biologic | Biologique | 212387 | 3010678 | BIOTHRAX | ANTHRAX VACCINE ADSORBED | RMP NDS | PGR PDN | 16-Feb-2018 | 16 févr. 2018 | 08-May-2018 | 8 mai 2018 | 16-Sep-2018 | 16 sept. 2018 | 0 | 0 | 1 | 2018 |
| MBBNHPB | BPBBSNC | Biologic | Biologique | 211541 | 3010633 | KAMRAB | ANTI-RABIES IMMUNOGLOBIN (HUMAN) | RMP NDS | PGR PDN | 12-Jan-2018 | 12 janv. 2018 | 27-Feb-2018 | 27 févr. 2018 | 04-Jun-2018 | 4 juin 2018 | 0 | 0 | 1 | 2018 |
| MBBNHPB | BPBBSNC | Biologic | Biologique | 210935 | 3010673 | JIVI | ANTIHEMOPHILIC FACTOR (RECOMBINANT), PEGYLATED | RMP NDS | PGR PDN | 08-Jan-2018 | 8 janv. 2018 | 13-Mar-2018 | 13 mars 2018 | 05-Jul-2018 | 5 juil. 2018 | 0 | 0 | 1 | 2018 |
| MBBNHPB | BPBBSNC | Biologic | Biologique | 208364 | 3010585 | DWP-40 | BOTULINUM TOXIN TYPE A | RMP NDS | PGR PDN | 20-Oct-2017 | 20 oct. 2017 | 30-Jan-2018 | 30 janv. 2018 | 29-May-2018 | 29 mai 2018 | 0 | 0 | 1 | 2018 |
| MBBNHPB | BPBBSNC | Biologic | Biologique | 213303 | 3010803 | VYNCRO | CANAKINUMAB | RMP NDS | PGR PDN | 25-Sep-2018 | 25 sept. 2018 | 20-Jan-2019 | 20 janv. 2019 | 0 | 0 | 1 | 2018 | ||
| MBBNHPB | BPBBSNC | Biologic | Biologique | 212066 | 3010657 | UNITUXIN | DINUTUXIMAB | RMP NDS | PGR PDN | 01-Feb-2018 | 1 févr. 2018 | 09-May-2018 | 9 mai 2018 | 16-Sep-2018 | 16 sept. 2018 | 0 | 0 | 1 | 2018 |
| MBBNHPB | BPBBSNC | Biologic | Biologique | 214080 | 3010766 | NIVESTYM (BIOSIMILAR TO NEUPOGEN) | FILGRASTIM | RMP NDS | PGR PDN | 16-Apr-2018 | 16 avr. 2018 | 13-Jun-2018 | 13 juin 2018 | 16-Oct-2018 | 16 oct. 2018 | 0 | 0 | 1 | 2018 |
| MBBNHPB | BPBBSNC | Biologic | Biologique | 212016 | 3010677 | ZARXIO (BIOSIMILAR TO NEUPOGEN) | FILGRASTIM | RMP NDS | PGR PDN | 05-Feb-2018 | 5 févr. 2018 | 08-May-2018 | 8 mai 2018 | 17-Sep-2018 | 17 sept. 2018 | 0 | 1 | 0 | 2018 |
| MBBNHPB | BPBBSNC | Biologic | Biologique | 207,702,208,107,208,000 | 3010516 | TRUMIXA | RITUXIMAB | RMP NDS | PGR PDN | 08-Sep-2017 | 8 sept. 2017 | 28-Nov-2017 | 28 nov. 2017 | 12-Apr-2018 | 12 avr. 2018 | 0 | 1 | 0 | 2018 |
| MBBNHPB | BPBBSNC | Biologic | Biologique | 214058 | 3010742 | RIXATHON | RITUXIMAB | RMP NDS | PGR PDN | 20-Apr-2018 | 20 avr. 2018 | 19-Jul-2018 | 19 juil. 2018 | 19-Nov-2018 | 19 nov. 2018 | 0 | 0 | 1 | 2018 |